NLRC5 and neoplasm: Univariate analysis showed NLRC5 expression level (HR = 1.79,95% CI 1.03–3.12, p = .041), AFP (HR = 1.72,95% CI 1.06–2.81, p = .030), tumor number (HR = 2.15,95% CI 1.31–3.50, p = .002), MVI (HR = 2.37,95% CI 1.41–3.97, p = .001), envelope invasion (HR = 2.33, 95% CI 1.41–3.84, p = .001), Child-Pugh classification (HR = 0.13, 95% CI 0.07–0.26, p = .001), and BCLC staging (HR = 2.81, 95% CI 1.61–4.90, p = .001) were risk factors for OS in patients (Table 3).